VWA
AUPH icon

Visionary Wealth Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Visionary Wealth Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,700
Closed -$123K – 449
2023
Q2 		$123K Hold
12,700
– – 0.01% 443
2023
Q1 		$139K Buy
12,700
+2,000
+19% +$17.6K 0.01% 430
2022
Q4 		$46K Hold
10,700
– – ﹤0.01% 413
2022
Q3 		$80K Sell
10,700
-1,000
-9% -$8.66K 0.01% 384
2022
Q2 		$118K Buy
11,700
+1,000
+9% +$11.2K 0.01% 408
2022
Q1 		$132K Buy
+10,700
New +$165K 0.01% 418

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Visionary Wealth Advisors's AUPH Position: Q3 2023 in Review

Visionary Wealth Advisors sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2023, closing a stake of 12,700 shares — an estimated $123K sold.

Visionary Wealth Advisors first reported a position in AUPH in Q1 2022 and held it in 6 quarters. The position peaked at $139K in Q1 2023. 198 funds tracked by Wall St. Rank hold AUPH as of Q3 2023.

  • Visionary Wealth Advisors reported no remaining Aurinia Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Visionary Wealth Advisors sold 12,700 Aurinia Pharmaceuticals shares in Q3 2023, an estimated $123K.
  • Visionary Wealth Advisors first reported a position in Aurinia Pharmaceuticals in Q1 2022 and held it in 6 quarters.
  • Visionary Wealth Advisors's Aurinia Pharmaceuticals position peaked at $139K in Q1 2023.
  • 198 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2023.

Based on Visionary Wealth Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.